Sheridan, J.(2018). Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: The GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772). BMJ Open Gastroenterology, 5(1), e000174. doi:10.1136/bmjgast-2017-000174